“Our findings suggest that GLP-1 receptor agonists may offer benefits beyond their effects on weight and glucose control, ...

Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

In a study, type 2 diabetes patients with obesity who had weight-loss surgery lost more weight, achieved better blood sugar ...

The results of this landmark trial are particularly significant, as oral therapies for obesity could improve both access to ...

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...

Paris, France, Thursday, 18 September 2025) Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower ...

The drug. orforglipron, works on the same receptor as semaglutide (Ozempic/Wegovy), but can be taken without restrictions on food or water intake.

Eli Lilly appears to have regained the lead over Novo Nordisk in the oral cardiometabolic treatment arena, following results ...

The largest and most comprehensive meta-analysis to date on glucagon-like peptide-1 (GLP-1) receptor agonists reveals ...

Dr. Earim Chaudry was warned people not to use the so-called 'golden dose' that comes with Mounjaro and shared why ...

Regular physical activity following significant weight loss may provide greater protection against cardiovascular disease than pharmacological intervention with glucagon-like peptide-1 receptor ...